Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Hematopathy Hospital of Xi'an International Medical Center Hospital is a specialized clinical and research institution located in Xi'an, China. As a core division of one of China's largest private medical complexes, it focuses on the treatment of complex blood disorders through advanced therapeutic approaches. The hospital is a regional leader in hematopoietic stem cell transplantation and has established a robust program for adoptive cell therapies, particularly CAR-T cell treatments. It actively conducts clinical trials for hematologic malignancies, including leukemia, lymphoma, and multiple myeloma, utilizing state-of-the-art cell processing facilities. The institution integrates high-volume clinical care with translational research to improve outcomes for patients with refractory hematological conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hematopathy Hospital of Xi'an International Medical Center Hospital.